Synthesis and antibody recognition of mucin 1 (MUC1)-α-conotoxin chimera

被引:1
|
作者
Drakopoulou, E
Uray, K
Mezo, G
Price, MR
Vita, C
Hudecz, F
机构
[1] Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Peptide Chem, H-1117 Budapest, Hungary
[2] CEA Saclay, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France
[3] Univ Nottingham, Dept Pharmaceut Sci, Canc Res Lab, Nottingham NG7 2RD, England
关键词
mucin; 1; epitope; alpha-conotoxin chimera; synthesis of cyclic peptides; solution conformation; antibody binding; synthetic antigen;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We synthesized and characterized new chimera peptides by inserting an epitope of the mucin 1 glycoprotein (MUC1) as a 'guest' sequence in the 'host' structure of alpha-conotoxin GI, a 13-residue peptide (ECCNPACGRHYSC) isolated from the venom of Conus geographus. The Pro-Asp-Thr-Arg (PDTR) sequence of MUC1 selected for these studies is highly hydrophilic and adopts a beta-turn conformation. The alpha-conotoxin GI also contains a beta-turn in the 8-12 region, which is stabilized by two disulphide bridges in positions 2-7 and 3-13. Thus, the tetramer sequence of alpha-conotoxin, Arg(9)-His-Tyr-Ser(12). has been replaced by PDTR comprising the minimal epitope for MUC1 specific monoclonal antibodies (MAbs) HMFG1 (PDTR) and HMFG2 [DTR]. Synthesis of the chimera peptide was carried out by Fmoc strategy on (4-(2',4'-dimethoxyphenyl-aminomethyl)phenoxy) (Rink) resin and either 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) or air oxidation was applied for the formation of the first Cys(3)-Cys(13) or Cys(2)-Cys(7) disulphide bridge, respectively. For the second disulphide bridge, three different oxidation procedures (iodine in acetic acid, 10% DMSO/1 M HCl or tallium trifluoroacetate (Tl(tfa)(3)) in TFA) were utilized. The HPLC purified peptides were characterized by electrospray mass spectrometry (ES-MS) and amino acid analysis. The CD spectra of the bicyclic MUCl-alpha-[Tyr(1)]-conotoxin chimera peptide showed partially ordered conformation with turn character. In antibody binding studies, the RIA data showed that both the linear and the bicyclic forms of MUC1-alpha-[Tyr(1)]-conotoxin chimera were recognized by MAb HMFG1 specific for PDTR sequence, while no binding was observed between MAb HMFG2 and various forms of the chimera. MAb HMFG1, using synthetic epitope conjugates or native MUC1 as target antigens, recognizes the PDTR motif more efficiently In the linear than in the bicyclic compound, but no reactivity was found with the monocyclic forms of MUC1-alpha-[Tyr(1)]-conotoxin chimera, underlining the importance of certain conformers stabilized by double cyclization. Copyright (C) 2000 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:175 / 185
页数:11
相关论文
共 50 条
  • [1] Synthesis and antibody recognition of synthetic antigens from MUC1
    Banoczi, Zoltan
    Mezo, Gabor
    Windberg, Emoke
    Uray, Katalin
    Majer, Zsuzsa
    Hudecz, Ferenc
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (05) : 610 - 616
  • [2] A novel monoclonal antibody specific for sialylated MUC1 mucin
    Yamamoto, M
    Bhavanandan, VP
    Nakamori, S
    Irimura, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (05): : 488 - 496
  • [3] MUC1 Mucin A Peacemaker in the Lung
    Kim, K. Chul
    Lillehoj, Erik P.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2008, 39 (06) : 644 - 647
  • [4] Antibody recognition of fluorinated MUC1 glycopeptide antigens
    Oberbillig, Thomas
    Mersch, Christian
    Wagner, Sarah
    Hoffmann-Roeder, Anja
    CHEMICAL COMMUNICATIONS, 2012, 48 (10) : 1487 - 1489
  • [5] MUC1 mucin in urological malignancy
    Scholfield, DP
    Simms, MS
    Bishop, MC
    BJU INTERNATIONAL, 2003, 91 (06) : 560 - 566
  • [6] Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
    Lakshminarayanan, Vani
    Thompson, Pamela
    Wolfert, Margreet A.
    Buskas, Therese
    Bradley, Judy M.
    Pathangey, Latha B.
    Madsen, Cathy S.
    Cohen, Peter A.
    Gendler, Sandra J.
    Boons, Geert-Jan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (01) : 261 - 266
  • [7] MUC1:: the polymorphic appearance of a human mucin
    Hanisch, FG
    Müller, S
    GLYCOBIOLOGY, 2000, 10 (05) : 439 - 449
  • [8] Human MUC1 mucin: a multifaceted glycoprotein
    von Mensdorff-Pouilly, S
    Snijdewint, FGM
    Verstraeten, AA
    Verheijen, RHM
    Kenemans, P
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 343 - 356
  • [9] Expression of MUC1 mucin in gastric carcinomas
    Arai, I
    Nakamori, S
    Furukawa, F
    Hiratsuka, M
    Tamura, S
    Kabuto, T
    Yasuda, T
    Kameyama, M
    Ohigashi, H
    Ishikawa, O
    Imaoka, S
    Nakano, H
    Sasaki, Y
    Iwanaga, T
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 417 - 420
  • [10] Detection of circulating mammary mucin (MUC1) and MUC1 immune complexes (MUC1-CIC) in healthy women
    Croce, MV
    Isla-Larrain, MT
    Price, MR
    Segal-Eiras, A
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (02): : 112 - 120